Correlation Between Regenerx Biopharm and Sosei Group
Can any of the company-specific risk be diversified away by investing in both Regenerx Biopharm and Sosei Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenerx Biopharm and Sosei Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenerx Biopharm In and Sosei Group, you can compare the effects of market volatilities on Regenerx Biopharm and Sosei Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenerx Biopharm with a short position of Sosei Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenerx Biopharm and Sosei Group.
Diversification Opportunities for Regenerx Biopharm and Sosei Group
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Regenerx and Sosei is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regenerx Biopharm In and Sosei Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sosei Group and Regenerx Biopharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenerx Biopharm In are associated (or correlated) with Sosei Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sosei Group has no effect on the direction of Regenerx Biopharm i.e., Regenerx Biopharm and Sosei Group go up and down completely randomly.
Pair Corralation between Regenerx Biopharm and Sosei Group
If you would invest 591.00 in Sosei Group on May 6, 2025 and sell it today you would earn a total of 29.00 from holding Sosei Group or generate 4.91% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Regenerx Biopharm In vs. Sosei Group
Performance |
Timeline |
Regenerx Biopharm |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Sosei Group |
Regenerx Biopharm and Sosei Group Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regenerx Biopharm and Sosei Group
The main advantage of trading using opposite Regenerx Biopharm and Sosei Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenerx Biopharm position performs unexpectedly, Sosei Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sosei Group will offset losses from the drop in Sosei Group's long position.Regenerx Biopharm vs. Pharmather Holdings | Regenerx Biopharm vs. Regen BioPharma | Regenerx Biopharm vs. Regen BioPharma | Regenerx Biopharm vs. Mymetics Corp |
Sosei Group vs. Atea Pharmaceuticals | Sosei Group vs. BridgeBio Pharma | Sosei Group vs. Coya Therapeutics, Common | Sosei Group vs. Idorsia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |